Universal immunization programs have been implemented in many countries worldwide and have significantly lowered the incidence and spread of infectious disease. The effective measles, mumps, and rubella (MMR) vaccine is widely administered globally (1); however, recent studies have demonstrated a decline in protective antirubella antibodies in countries with universal vaccination programs, including among women of reproductive age-thus increasing the risk of rubella infection and severe birth defects due to congenital rubella syndrome (2,3).While various factors have been associated with declining rubella immunity following childhood immunization, Hui et al. (4) present compelling evidence in this issue to suggest that elevated body mass index (BMI) may impair serological immunity against rubella in pregnant women. In this large-scale retrospective cohort study, pregnant women with BMI > 25.0 kg/m 2 were more likely to present with serological rubella nonimmunity (rubella IgG antibody titer < 10 IU/mL), as compared to women with BMI < 25.0 kg/m 2 . Interestingly, the risk of rubella nonimmunity in women with high BMI was greater in women born in Hong Kong, where rubella immunization is mandatory during childhood. The positive association between rubella nonimmunity and high BMI persisted after controlling for potential confounding factors, such as maternal age, parity, short stature, and year and location of birth, which could impact participation in immunization programs.Obesity can impair the regulation of immune responses by promoting lipid deposition in lymphoid tissues, alterations in leukocyte profiles and activity, and chronic inflammation. While studies have previously demonstrated that obesity negatively impacts the efficacy of vaccines against influenza, hepatitis B, and tetanus (5), the current work of Hui et al. (4) is novel in that it is one of few studies to find an association between high BMI and immunity against rubella and the first study to identify this trend in pregnant women-a population most at risk for conferring severe effects of rubella infection to offspring.While obesity initiatives often focus on reducing the risk of chronic diseases stemming from metabolic dysfunction (e.g., cardiovascular disease, type 2 diabetes mellitus) (5), these findings emphasize the importance of targeting overweight and obesity as a means to reduce the risk of infectious disease. Given that this current study was conducted in geographical areas where mandatory rubella immunization programs have been implemented, these findings call into question the long-term success of these initiatives in preventing rubella outbreaks where the prevalence of overweight and obesity is high. Further investigation may be warranted to determine the need for serological screening and booster immunizations on the basis of BMI, particularly within the context of antenatal care, as a means to promote population health.O